Search clinical trials for: bleeding risk, acute coronary syndrome, platelet agregation,

Total 41015 results

University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Mechanistic Study of Bleeding Risk in Coronary Patients With Cerebrovascular Disease

Coronary Artery Disease | Cerebral Stroke | TIA (Transient Ischemic Attack)

Brazil
Medical University of Warsaw

Completed

Multimarker Evaluation of Platelet Activity and Agregation in ACS

Acute Coronary Syndrome

Poland
University Medical Centre Ljubljana

Recruiting

Platelet Agregation in Patients on ECMO

Platelet Refractoriness

Slovenia
Les Laboratoires des Médicaments Stériles

Completed

Clinical Assessment of Pidogrel® Versus Plavix® (CAPP) ((CAPP))

Coronary Disease

Tunisia
Assistance Publique Hopitaux De Marseille

Recruiting

Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome (INNOV CKD 1)

Chronic Kidney Disease stage3

France
Azienda Ospedaliera Universitaria Policlinico "G...
Gianluca Di Bella; Antonio Micari; Giampiero Vizzari; Giorgio Quadri; Greca Zanda; Ferdinando...

Recruiting

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS (DESC-HBR)

Coronary Artery Disease | Acute Coronary Syndrome | Dual Antiplatelet Therapy

Italy
Seoul National University Hospital
Hanyang University

Recruiting

HOST - DAPT Duration According the Bleeding Risk (HOST-BR)

Coronary Artery Disease | Stable Angina | Acute Myocardial Infarction

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
Fonds de Dotation ACTION

Not yet recruiting

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome (ADEN)

MYOCARDIAL INFARCTION

France
Universita degli Studi di Genova
Università degli Studi della Campania Luigi Vanvitelli

Recruiting

Intravenous CAngrelor in High-bleeding Risk Patients Undergoing percutaneouS Coronary Intervention (ICARUS) Registry (ICARUS)

Myocardial Infarction | Coronary Artery Disease | Bleeding

Italy
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients (LEGACY)

Non ST Segment Elevation Acute Coronary Syndrome

Netherlands
St. Antonius Hospital
Daiichi Sankyo, Inc.

Recruiting

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? (WOEST-3)

Myocardial Infarction | Coronary Artery Disease | Stroke | Embolism | Atrial Fibrillation | Bleeding | Acute Coronary Syndrome | Atrial Flutter | NSTEMI - Non-ST Segment Elevation MI | Stent Thrombosis | STEMI - ST Elevation Myocardial Infarction

Belgium, Netherlands
Kyoto University, Graduate School of Medicine

Active, not recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study (STOPDAPT-3)

Acute Coronary Syndrome

Japan
Ottawa Heart Institute Research Corporation

Active, not recruiting

The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (CAPITAL PCI AF)

Atrial Fibrillation | Acute Coronary Syndrome

Canada
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding

Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months

Korea, Republic of
Liverpool University Hospitals NHS Foundation Trust
Liverpool Heart and Chest Hospital NHS Foundation Trust; Countess of Chester... and other collaborators

Completed

The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome (ROBOT-ACS)

Bleeding | Acute Coronary Syndrome | Ticagrelor | Clopidogrel | Novel Anti-platelets

United Kingdom
Biosensors Europe SA

Active, not recruiting

LEADERS FREE II: BioFreedom™ Pivotal Study

Acute Coronary Syndrome | High Bleeding Risk

United States, Canada, France, Italy, United Kingdom, Germany, Denmark
Gyeongsang National University Hospital

Completed

Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome

Bleeding | Acute Coronary Syndrome | Platelet Thrombus

Korea, Republic of
University of Sao Paulo General Hospital

Completed

Evaluation of Platelet Aggregability in the Release of CABG in Patients With ACS With DAPT.

Bleeding

Brazil
R&D Cardiologie
St. Antonius Hospital

Unknown

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. (WOEST 2)

Myocardial Infarction | Stroke | Bleeding | Acute Coronary Syndromes | Coronary Artery Diseases | Atrial Fibrillations | Heart Valve Prostheses

Belgium, Netherlands
Humanitas Hospital, Italy

Unknown

Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT (POEM)

Coronary Artery Disease | Acute Coronary Syndrome

Italy
Medical University of Graz

Terminated

Bleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet Therapy

Acute Coronary Syndrome

Austria
St. Antonius Hospital
UMC Utrecht; Leiden University Medical Center; Medical Centre Leeuwarden; Rijnstate... and other collaborators

Unknown

Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly (POPular AGE)

Unstable Angina | Non-ST-elevation Acute Coronary Syndrome | Non-ST-elevation Myocardial Infarction

Netherlands
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Completed

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk (RAPID MANAGE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada
Hospital Álvaro Cunqueiro

Unknown

Registry of Acute Coronary Syndrome From University Hospital of Vigo (CardioCHUVI)

Acute Coronary Syndrome

Spain
Baim Institute for Clinical Research
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Boston Scientific... and other collaborators

Completed

The Dual Antiplatelet Therapy Study (DAPT Study)

Coronary Artery Disease

United States, Australia, Czechia, New Zealand, United Kingdom, Germany, Hungary, Poland, France, Romania
General Hospital of Chinese Armed Police Forces

Completed

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

Non ST Segment Elevation Acute Coronary Syndrome

China
David Antoniucci
A.R. CARD Onlus Foundation

Terminated

BLeeding Events and Maintenance DoSe of PraSugrel (BLESS)

Acute Coronary Syndrome | Adverse Reaction to Antiplatelet Agent

Italy
AstraZeneca

Completed

Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

Bleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, Gout

Sweden
Italian Society of Invasive Cardiology
Eustrategy

Unknown

Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)

STEMI | Acute Coronary Syndromes | NSTEMI

Italy
Ruttonjee Hospital

Completed

Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease

Acute Coronary Syndrome | Acute Myocardial Infarction

China
Medco Health Solutions, Inc.

Terminated

Genotype Guided Comparison of Clopidogrel and Prasugrel Outcomes Study (GeCCO)

Cardiovascular Disease

United States
Zunyi Medical College

Recruiting

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

ACS - Acute Coronary Syndrome | CYP2C19 Polymorphism

China
Medical University of Warsaw

Recruiting

Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome (LowASA-PCI)

Myocardial Infarction | Acute Coronary Syndrome

Poland
Wuhan Union Hospital, China

Not yet recruiting

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Infections | Acute Myeloid Leukemia | Anemia | Bleeding | Thrombocytopenia | Neutropenia
Shenyang Northern Hospital

Not yet recruiting

OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time (OPT-GUIDNACE)

Acute Coronary Syndrome

China
Unity Health Toronto

Not yet recruiting

A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWD (EMPOWER)

Von Willebrand Diseases
Fu Wai Hospital, Beijing, China

Not yet recruiting

Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease

Coronary Heart Disease

China
iVascular S.L.U.

Not yet recruiting

Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy (ANGIODAPT)

Coronary Artery Disease
St. Antonius Hospital

Recruiting

POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy (POPular GUILTY)

Acute Coronary Syndrome | CYP2C19 Polymorphism

Netherlands
Mina Wageh Mohareb
Al-Azhar University

Recruiting

Individualized and Combined Effects of Diabetes and Smoking on the Antiplatelet Activity of Ticagrelor in Acute Myocardial Infarction Patients Undergoing Primary PCI

Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary Percutaneous Coronary Intervention

Egypt
Daejeon St. Mary's hospital
Jeil Pharmaceutical Co., Ltd.

Not yet recruiting

The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) (PPI)

Coronary Artery Disease
Collegium Medicum w Bydgoszczy

Not yet recruiting

Prasugrel Or Ticagrelor De-escalation in NSTE-ACS (PROTEUS)

Unstable Angina | Non ST Segment Elevation Acute Coronary Syndrome | Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)

Poland
University Hospital Heidelberg
AstraZeneca

Recruiting

Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients With Acute Coronary Syndrome in a Real-world Registry (AZ-DAPT)

Acute Myocardial Infarction

Germany
Hospital Israelita Albert Einstein

Recruiting

Platelet Sub-study of the Neomindset Trial

Acute Coronary Syndrome

Brazil
Kindai University
Boston Scientific Corporation

Recruiting

PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction (PREMIUM)

ST-segment Elevation Myocardial Infarction (STEMI)

Japan
University of Florida

Recruiting

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI (TAILOR BLEED)

Coronary Artery Disease

United States
China National Center for Cardiovascular Diseases

Recruiting

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

China
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets (BAT-VTE)

Venous Thromboembolic Disease

France
Sarmad Zahoor
Mayo Hospital Lahore; University of Managemant and Technology, Pakistan

Not yet recruiting

To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome (ACCP)

Acute Coronary Syndrome
University of Texas Southwestern Medical Center

Recruiting

Polypill in Acute Coronary Syndrome (POLY-ACS)

Coronary Artery Disease | Acute Coronary Syndrome | Lipid Disorder

United States

Search clinical trials for: bleeding risk, acute coronary syndrome, platelet agregation,

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations